PORTACCI, ANDREA
 Distribuzione geografica
Continente #
NA - Nord America 1.430
AS - Asia 746
EU - Europa 665
SA - Sud America 159
Continente sconosciuto - Info sul continente non disponibili 114
AF - Africa 48
Totale 3.162
Nazione #
US - Stati Uniti d'America 1.348
SG - Singapore 311
IT - Italia 287
BR - Brasile 123
CN - Cina 101
DE - Germania 100
HK - Hong Kong 95
BD - Bangladesh 67
RU - Federazione Russa 64
VN - Vietnam 61
FR - Francia 59
GB - Regno Unito 43
CA - Canada 34
IN - India 34
CI - Costa d'Avorio 19
NL - Olanda 15
PL - Polonia 15
MX - Messico 13
SE - Svezia 13
CR - Costa Rica 12
FI - Finlandia 12
ES - Italia 11
ID - Indonesia 11
IQ - Iraq 11
AT - Austria 9
LT - Lituania 9
AR - Argentina 8
JP - Giappone 8
ZA - Sudafrica 8
CO - Colombia 7
EC - Ecuador 7
IE - Irlanda 7
VE - Venezuela 7
CZ - Repubblica Ceca 6
IL - Israele 6
MY - Malesia 6
TR - Turchia 6
EG - Egitto 5
MA - Marocco 5
PK - Pakistan 5
SA - Arabia Saudita 5
NI - Nicaragua 4
TT - Trinidad e Tobago 4
BS - Bahamas 3
CH - Svizzera 3
CL - Cile 3
JO - Giordania 3
NP - Nepal 3
PH - Filippine 3
UA - Ucraina 3
AE - Emirati Arabi Uniti 2
BE - Belgio 2
CW - ???statistics.table.value.countryCode.CW??? 2
DZ - Algeria 2
ET - Etiopia 2
GT - Guatemala 2
HN - Honduras 2
HR - Croazia 2
JM - Giamaica 2
PR - Porto Rico 2
SC - Seychelles 2
SN - Senegal 2
SV - El Salvador 2
TH - Thailandia 2
UY - Uruguay 2
UZ - Uzbekistan 2
BH - Bahrain 1
BJ - Benin 1
BN - Brunei Darussalam 1
BO - Bolivia 1
DO - Repubblica Dominicana 1
GP - Guadalupe 1
GR - Grecia 1
HU - Ungheria 1
IR - Iran 1
KZ - Kazakistan 1
LY - Libia 1
PE - Perù 1
PT - Portogallo 1
RO - Romania 1
RS - Serbia 1
TN - Tunisia 1
Totale 3.050
Città #
Ashburn 215
Singapore 167
San Jose 157
Council Bluffs 120
Hong Kong 93
Milan 81
Los Angeles 53
Beijing 41
Dallas 40
New York 39
Munich 34
Columbus 29
Rome 28
Santa Clara 27
Boardman 26
Falkenstein 25
Lauterbourg 24
Phoenix 22
Ho Chi Minh City 20
Abidjan 19
Buffalo 18
Chicago 18
Frankfurt am Main 18
São Paulo 18
Chandler 16
Hanoi 13
Bari 12
Atlanta 11
London 11
Montreal 11
Helsinki 10
Houston 10
Orem 10
Warsaw 10
Brooklyn 9
Florence 9
North Bergen 9
Nuremberg 9
Stockholm 8
Tokyo 8
Baghdad 7
Denver 7
Elk Grove Village 7
Manchester 7
Naples 7
San José 7
Toronto 7
Kuala Lumpur 6
Tampa 6
Ankara 5
Chennai 5
Jakarta 5
Johannesburg 5
Mexico City 5
Nyköping 5
Seattle 5
Vienna 5
Belo Horizonte 4
Bologna 4
Brasília 4
Charlotte 4
Dublin 4
Haiphong 4
Mumbai 4
Olomouc 4
Padua 4
Pittsburgh 4
Rio de Janeiro 4
Trani 4
Amman 3
Amsterdam 3
Belford Roxo 3
Boston 3
Buenos Aires 3
Calgary 3
Da Nang 3
Detroit 3
Düsseldorf 3
Erbil 3
Figino 3
Fiorenzuola d'Arda 3
Hải Dương 3
Lấp Vò 3
Managua 3
Medellín 3
Miami 3
Miano 3
Paris 3
Parma 3
Poplar 3
Pune 3
Riyadh 3
Roubaix 3
Salt Lake City 3
Sterling 3
The Bronx 3
Turin 3
Washington 3
Addis Ababa 2
Agrigento 2
Totale 1.738
Nome #
Effectiveness and safety of anti-IL-5/Rα biologics in eosinophilic granulomatosis with polyangiitis: a two-year multicenter observational study 148
A glimpse in post-COVID pathophysiology: the role of exhaled breath condensate pH as an early marker of residual alveolar inflammation 134
Advancing Care in Severe Asthma: The Art of Switching Biologics 119
Short-term Tezepelumab effectiveness in patients with severe asthma: a multicentre study 118
Effect of Food Intake on Exhaled Volatile Organic Compounds Profile Analyzed by an Electronic Nose 115
Electronic Nose Analysis of Exhaled Breath Volatile Organic Compound Profiles during Normoxia, Hypoxia, and Hyperoxia 110
Assessment of Five Questionnaires for Chronic Obstructive Pulmonary Disease in a Southern Italian Population: A Proof-of-Concept Study 108
Managing Small Airway Disease in Patients with Severe Asthma: Transitioning from the “Silent Zone” to Achieving “Quiet Asthma” 106
The Predictors of Long COVID in Southeastern Italy 97
Early Prediction of In-Hospital Mortality in Patients with Acute Infections: Development of the Acute Severity Infection Score (ASIs) 94
The impact of healthcare setting on post-COVID mood disorders: a single-centre perspective from Southern Italy Respiratory Intensive Care Unit 93
Real-life effects of dupilumab in patients with severe type 2 asthma, according to atopic trait and presence of chronic rhinosinusitis with nasal polyps 92
Asthma and Fixed Airways Obstruction: Real Life Aspects 91
Galectin-3 as prognostic biomarker in patients with COVID-19 acute respiratory failure 91
Features of severe asthma response to anti-IL5/IL5r therapies: identikit of clinical remission 91
Clinical Remission Predictors in Non-Colonized Bronchiectasis and Severe Asthma with Type 2-Targeted Biologic Therapy: A Retrospective Real-Life Pilot Study 91
Female gender and psychological profile of outpatients attending Post-COVID-19 follow-up: some preliminary results 90
Divergences in chronic cough management among healthcare professionals in Southern Italy: A comprehensive survey 87
Benralizumab Effectiveness in Severe Eosinophilic Asthma with Co-Presence of Bronchiectasis: A Real-World Multicentre Observational Study 87
Real-world characteristics of "super-responders" to mepolizumab and benralizumab in severe eosinophilic asthma and eosinophilic granulomatosis with polyangiitis 86
Electronic nose based analysis of exhaled volatile organic compounds spectrum reveals asthmatic shifts and consistency in controls post-exercise and spirometry 85
Therapeutic Potential of Glucagon-like Peptide-1 Receptor Agonists in Obstructive Sleep Apnea Syndrome Management: A Narrative Review 83
Severe asthma clinical remission after biologic treatment with anti-IL4/IL13: A real-life experience 83
Role of Free Radicals in the Pathophysiology of OSA: A Narrative Review of a Double-Edged Sword 80
Can Galectin-3 be a reliable predictive biomarker for post-COVID syndrome development? 77
Can single-inhaler Beclometasone Dipropionate/Formoterol Fumarate/Glycopyrronium therapy postpone or save biologics for severe asthma? 73
Real-life preliminary evidence for basophils as predictors of Tezepelumab response in severe asthma 55
Bridging Gaps in Occupational Respiratory Disease Management: A Comparative Survey of Pulmonologists and Occupational Physicians in Italy 52
The impact of PAP therapy first impression on short-term treatment adherence 50
Reply to "Have we reached our final destination with biologics in severe uncontrolled asthma?" 49
Diaphragm function in patients with asthma and healthy controls: A cross-sectional study 45
The impact of tezepelumab therapy on perceived asthma triggers: a multicenter real-life study 43
Effect of the Arg16Gly β2-Adrenergic Receptor Polymorphism on Long-Term Mepolizumab Response and Clinical Remission in Severe Eosinophilic Asthma: A Genotype-Stratified, Multicenter Study 42
Type-2 severe asthma comorbidities in the era of biologics: time to rethink clinical response? 42
Super-Responders to Biologic Treatment in Type 2-High Severe Asthma: Passing Fad or a Meaningful Phenotype? 35
FeNO 350 mL/s: Unlocking the Small Airways to Achieve Clinical Remission in Severe Asthma-A Pilot Study 34
Steady Quiet Asthma Without Biologics: One-Year Outcomes of Single-Inhaler Triple Therapy for Severe Asthma with Small Airway Dysfunction 30
Predictive factors of body weight loss in patients with type 2 diabetes treated with GLP-1 receptor agonists: a 52-week prospective real-life study 29
Reconsidering Gender in Asthma: Is It All About Sex? A Perspective Review 25
Why Every Asthma Patient Tells a Different Story 16
Electronic Nose-Based Exhaled Volatile Organic Compound Pattern Recognition and Multivariate Signal Analysis for Discriminating Idiopathic Pulmonary Fibrosis from Autoimmune Usual Interstitial Pneumonia 13
Nationwide trends in AECOPD care in Italy before, during and after COVID-19: discrepancies between data sources and across regions 13
High Concordance of E-Nose-Derived Breathprints in a Healthy Population: A Cross-Sectional Observational Study 12
Physical activity levels and influencing factors in individuals with bronchiectasis: a cross-sectional study 12
Prescription patterns and clinical rationales for corticosteroid use in respiratory infections: A cross sectional survey of medical specializations 12
Can Sleep Hypoxic Measures Predict Long-Term Adherence to Positive Airway Pressure Treatments? 9
Real-Life Characteristics of Patients with COPD and Discordant CAT-mMRC Questionnaires 8
Exploratory Identification of Multidimensional COPD Clusters Using Unsupervised Analysis 7
Totale 3.162
Categoria #
all - tutte 10.988
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.988


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/202340 0 0 0 2 6 9 0 6 8 1 4 4
2023/202451 6 4 1 4 7 18 0 1 4 0 1 5
2024/2025491 22 9 0 21 15 38 35 62 11 55 74 149
2025/20261.890 191 54 97 197 271 143 196 46 213 185 122 175
2026/2027690 126 90 179 265 30 0 0 0 0 0 0 0
Totale 3.162